Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin and Albuminuria Progression in High CV Risk T2DM (China cohort of CANVAS/related)
CTR20150180Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of canagliflozin in type 2 diabetes mellitus (T2DM), albuminuria, chronic kidney disease (CKD), sponsored by Janssen Pharmaceutical. Started Apr 2015; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)albuminuriachronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20150180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150180.